wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40846805-92D7F803-BFA9-4475-A643-69633525F245
Q40846805-92D7F803-BFA9-4475-A643-69633525F245
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40846805-92D7F803-BFA9-4475-A643-69633525F245
Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma.
P1476
Q40846805-92D7F803-BFA9-4475-A643-69633525F245
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40846805-92D7F803-BFA9-4475-A643-69633525F245
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
467fa04dcee4fa09c7fa74dfdddd1a8a39f30c32
P1476
Concurrent sorafenib therapy e
......
able hepatocellular carcinoma.
@en